Nancy Parsons
Recent First Amendment Rumblings
Focus on Regulation ·
FDA Withdraws Draft Disease Awareness Guidance
Focus on Regulation ·
Less is More in FDA’s Eyes: FDA’s Revised Draft Guidance on Disclosing Risk Information
Focus on Regulation ·
FDA Issues Revised Draft Guidance on Reporting Drug Sample Information Under the ACA
Focus on Regulation ·
FDA Provides New Framework for Drug and Device Promotion on Twitter and Search Engines
Focus on Regulation ·